PR Newswire Asia's news > Biotechnology

 < Previous page   |   Detail   |   Print    Next page > 
     
Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer
2026-09-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Harbour BioMed Partner, Solstice Oncology, announces $225 Million Series A Financing to Advance Porustobart, a Neoadjuvant Immuno-Oncology Therapy
2026-09-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
HanchorBio Reaches Clinical Milestone for HCB101 as US FDA Allows Continued Treatment for Phase 1 Patient Experiencing Clinical Benefit
2026-09-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
ZAGENO Earns Frost & Sullivan's 2026 North American Life Sciences E‑Commerce Company of the Year Recognition
2026-09-09T    Biotechnology   Computer Software   Electronic Commerce 
Lunit Unveils New AI-Powered Tumor Microenvironment Insights in Lung Cancer at WCLC 2026
2026-09-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Metabolon Verus™ Metabolomics Profiling Kit Now Available to Order
2026-09-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Accro Bioscience Announces IND Clearance from NMPA for Phase II/III Clinical Trial of AC-201, a Highly Selective TYK2/JAK1 Inhibitor for the Treatment of Non-Segmental Vitiligo
2026-09-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
HBM9378/WIN378, an Ultra-Long-Acting Antibody Targeting TSLP, Achieves Positive Phase 2 Results in Asthma and Initiates Phase 3 Study
2026-09-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Alebund Pharmaceuticals Announces FDA Clearance of IND Application for AP308 for the Treatment of IgA Nephropathy
2026-09-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Kelun-Biotech's Partner Windward Bio Announces Positive Phase 2 Results of SKB378/WIN378 in Asthma, and Initiates Phase 3 Study
2026-09-08T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.